Currently, infection of macaques with simian immunodeficiency virus (SIV) or the derived chimeric simian/ human immunodeficiency virus (SHIV) is recognized as being a highly relevant experimental model to study human immunodeficiency virus (HIV) infection in humans. The easy access to tissues at the mucosal front line, as well as to draining lymphoid tissues, which is clearly not feasible in humans exposed to HIV type 1 (HIV-1), make the nonhuman primate model particularly useful to characterize early events taking place after mucosal exposure and to assess new strategies to prevent sexual transmission of HIV-1. Indeed, numerous studies have provided insight into how SIV/SHIV enter the mucosa and have detailed the earliest steps of infection within the first hours and weeks following genital or rectal exposure [1] [2] [3] . Macaques of different origins (India, China, and Mauritius) have thus become the most commonly used and widely accepted models also for the preclinical safety and efficacy testing of candidate antiretrovirals, vaccines, and microbicides.
The rectal and vaginal challenge models in nonhuman primates have extensively used SIV/SHIV cellfree viral particles to evaluate preventive approaches. However, most of the time studies have neglected that humans are exposed to contaminated body fluids in which diverse virus forms (eg, cell-free and cell-associated virus) and that quasispecies may be present in a complex microenvironment. Although semen is a major clinically relevant source of infectious HIV-1, little is known about the mechanisms by which HIV-1 present in semen may cross the mucosal barriers. Moreover, the contributions of both viral and nonviral semen factors on viral transmission and pathogenesis have also been poorly assessed in animal models.
Human semen comprises seminal plasma and cells, mainly represented by spermatozoa but also containing germ cells, leukocytes, epithelial cells, and commensal microflora. The seminal plasma contains thousands of different proteins [4] , including inflammatory factors, immune modulators such as transforming growth factor β (TGF-β) and prostaglandin E2, antiviral components such as defensins, and HIV-specific antibodies in infected men [5] . Semen factors have been shown to either inhibit or enhance HIV/SIV infections in in vitro models, acting through different mechanisms and cell types [6] [7] [8] [9] [10] . However, how these factors modulate HIV/SIV transmission and impact the efficacy of preventive approaches remains poorly understood.
LEUKOCYTES IN THE SEMEN OF SIV-INFECTED MACAQUES
Strong evidence argues for a role of cell-associated HIV in transmission. Cell-to-cell HIV transmission has been extensively described to be more efficient, rapid, and resistant to host immune responses than infection with cell-free virus particles [11] . Human semen contains variable numbers of polymorphonuclear leukocytes, lymphocytes, and macrophages [12] , and in HIV-infected men the prevalence of HIV proviral DNA in seminal leukocytes ranges from 21% to 75% [13] . High leukocyte counts in semen have been associated with increased semen infectiousness [14] , and both macrophages and T cells isolated from semen of HIV-infected men were shown to be capable of transmitting HIV to peripheral blood mononuclear cell (PBMC) targets in vitro [15] . Leukocytes in semen can be of diverse origin. Various organs of the male genital tract, including the testis, epididymis, prostate, seminal vesicles, and bulbourethral glands, could seed the semen with infected cells. This is reviewed in detail by Houzet et al elsewhere in this issue [55] .
A limited number of studies have focused on the nature and phenotype of the infected cells in semen of nonhuman primates. Very similar to human semen, macaque semen contains leukocytes in variable numbers, which are mainly polymorphonuclear leukocytes (mean proportion [±SD], 26% ± 6.70%), macrophages (22.22% ± 5.06%), and lymphocytes (15.90% ± 4.29%) [16] . All major SIV host cells, including CD4+ T cells, dendritic cells (DCs), and macrophages, are present in semen of cynomolgus macaques at all stages of infection with pathogenic SIVmac251 [16] .
Semen CD4+ T cells have a profile typical of resident mucosal T cells [16] ; they are mostly central memory cells (CD95-+CD28+), and a large proportion express CD69, an activation marker highly expressed at all stages of infection. This phenotype is very close to the one described for T cells present in human semen [17] , which also strongly express CD69 and CD38. The differentiation and activation status makes these cells particularly well equipped to replicate the virus. Indeed, despite the fact that CD4+ T cells are rapidly and profoundly depleted in the semen of SIV-infected macaques, SIV-DNA is detected in these cells at all stages of infection, and sorted CD4+ T cells from semen can very efficiently transmit SIV to permissive cells in vitro [16] . At early stages of infection, before CD4+ T cells are depleted, these cells may be important mediators of cell-associated SIV infection. However, in the context of chronic infection of macaques with SIV, CD4+ T cells in semen are present in very small numbers, and we surmise that if present in similar numbers, the impact of corresponding HIVinfected T cells in humans on virus transmission is therefore probably limited.
In contrast to seminal CD4+ T cells, macrophages predominate in semen of macaques at all stages of SIV infection and also transmit infection to cocultured cell lines [16] . Seminal macrophages constitute a heterogeneous population, with different levels of CD163, CD14, and CD11b expression. The majority are CD11b+CD163 bright , a profile typical of activated cells.
All express CD4, and most are CCR5+. This phenotype is very similar to the one of the macrophages resident in the human female genital tract, the urethra, and the foreskin [18] . In the context of chronic infection of macaques with SIV, infected macrophages may play a critical role in cell-associated virus transmission. The predominance of CCR5+ viral host cells (both T lymphocytes and macrophages) might account for the predominance of R5 virus transmission at the mucosal level and may also favor cell-associated transmission. Indeed, since semen leukocytes express not only CCR5 but also receptors such as CXCR3 (expressed on T cells), they should be able to migrate into tissues producing CCL5, CCL3, and CXCL10, such as the cervicovaginal mucosa. Furthermore, T cells and macrophages in semen from macaques express high levels of LFA-1 and/or MAC-1 integrins [16] , which play an important role in leukocyte adhesion to epithelial cells and transmigration and promote cell-cell interactions [19, 20] . LFA-1 is not only involved in the establishment of the virological synapse and HIV-1 cell-to-cell transmission, it also facilitates HIV-1 replication [21] . Interestingly, MAC-1 expression on semen macrophages is slightly increased in SIV-infected macaques [16] .
Other types of antigen-presenting cells, including DCs, were also detected in the semen of cynomolgus macaques; however, their capacity to be productively infected has not been reported to date. Considering that Langerhans cells (LCs) have been found in the human penile mucosa (glans, meatus, and foreskin), it would be of relevance to investigate the role of seminal LCs/DCs in viral transmission and dissemination.
CELL-ASSOCIATED SIV/SHIV TRANSMISSION TO NONHUMAN PRIMATES
The first evidence that infected cells can transmit HIV or SIV to primates was reported by Fultz et al, who demonstrated that an early HIV vaccine protected chimpanzees against HIV infection following injection of infected cells [22] . Further studies reported that persistent infection was obtained in adult chimpanzees after atraumatic exposure at the entrance of the cervical canal to various infectious doses of either cell-associated HIV-1 LA1 (IIIB) (PBMCs from an infected chimpanzee) or with cell-free HIV-1 strains representing subtypes B and E, but not with a subtype A strain. This study also indicated that productive infection of female chimpanzees via the cervicovaginal route with either cellassociated or cell-free virus generally requires >1 exposure [23] .
Transmission of infection to macaques by using cell-associated SIV has also been used to assess the efficacy of vaccine candidates. Initial studies reported that, in intravenous challenge models, protection was less efficient in SIV-vaccinated rhesus macaques challenged with homologous cell-associated stock, compared with animals challenged with cell-free particles of the same SIVmac32H strain [24, 25] . A higher degree of protection against intravenous cell-associated SIV challenge could be achieved in macaques immunized with live attenuated SIV [26] . Animals protected with the SIV vaccine were those sharing a particular major histocompatibility complex (MHC) class I allele (Mamu-A26) with the donor of the infected cells used to prepare the challenge stock, suggesting a particular role of MHC class I-restricted cytotoxic T lymphocytes in protection from exposure to infected blood cells [27] . In chimpanzees immunized with a live recombinant canarypox vaccine candidate expressing HIV-1 IIIB gp120/TM, gag, and protease gene products (ALVAC-HIV-1 vCP250), transmission was obtained with HIV-1-infected PBMCs inoculated intravenously in 1 of 2 vaccinated animals, as well as the control chimpanzee [28] , indicating that partial protection may be obtained in this species against cell-associated virus. A higher level of protection against intravenous challenge with homologous cell-associated HIV-1 was observed in chimpanzees vaccinated with a combination of inactivated HIV-1 and/or purified gp160 and a mixture of Gag, Vif, and Nef proteins and V3 peptides [22] .
Autologous immature DCs and T cells loaded ex vivo with SIV also transmit infection after subcutaneous injection. This approach was supposed to mirror what may happen if virusloaded cells pass through an epithelial barrier. Following the first days of infection, virus-producing CD4+ T cells in the draining lymph nodes (LNs) predominated in animals that received cell-free virus, whereas both SIV-positive macrophages and T cells were detected in the LNs of monkeys infected with cell-associated SIV. These results suggest that although both cell-free and cell-associated viruses are infectious, the initial interactions with host target cells may differ and may therefore impact the initial host response to infection [29] .
The vaginal mucosa of rhesus macaques is a strong but penetrable barrier to cell-free SIVmac251 infection. Likewise, although SIV-infected cells are very efficient in infecting macaques when given intravenously, animals are more resistant to cell-associated SIV when exposed by the vaginal route. An early study showed that intravenous transmission could be achieved with as few as 2 SIV-infected PBMCs, whereas as high as 10 000 SIV-infected PBMCs of the same stock failed to infect vaginally inoculated macaques. The same study demonstrated that cell-free SIV was more efficient than cell-associated HIV in transmitting mucosal infection [30] . However, a number of recent studies have shown efficient cell-associated SIV transmission via vaginal exposure. The first demonstration that persistent infection could be achieved in macaques after mucosal exposure to cell-associated SIV (in vitro-infected PBMCs) was obtained in models with induced genital ulcers [31, 32] . Mucosal disruption is common in genital coinfections in humans and makes the main target cells for HIV transmission more accessible. Also, during sexual intercourse, even in the absence of any violence, small abrasions or microbreaches of the epithelium are frequent in vaginal, penile, and rectal mucosa. Interestingly, it has been demonstrated that allogeneic cells from SIV-infected macaques can traffic from the vaginal lumen through ulcers to lymphatic tissues and rapidly disseminate into the systemic compartment of recipient female macaques [32] . More recently, efficient transmission was achieved with cellassociated SIV in vaginally exposed progesterone-treated female cynomolgus macaques in the absence of detectable ulcers. In this study, the cell-associated SIV stock was made from splenocytes obtained from a macaque at the peak of infection (day 14) with SIVmac251 [33] . Similar to previous findings in nonhuman primates and mice models [32, 34] CFSE-labeled cells of the cellassociated SIV stock, mostly T cells, were detected in vaginal tissues and the draining internal iliac LN as early as 21 hours after inoculation. These cells were confirmed to be SIV-positive cells by in situ hybridization. Of particular interest, 45 hours after inoculation, CFSE-positive cells were also detected in the axillary LN, suggesting a very fast dissemination of the inoculated SIV to distant tissues, much more rapid than what was reported after vaginal exposure to high dose of cell-free SIV [1] .
Cell-associated virus also efficiently transmits infection across the intestinal mucosa. Repeated rectal exposure to low amounts of SIV-infected PBMCs (92 median tissue culture infective doses) transmitted infection to recipient macaques [35] , whereas similar low doses of cell-free SIV did not transmit infection. The high efficiency of PBMCs to cross the colonic epithelium was confirmed in ex vivo explant cultures sealed with gel to avoid viral penetration through the cut sides of the explant. In this system, cell-free SIVmac251 was not able to transmit infection, whereas SIV-infected PBMCs not only penetrated into the colon epithelial layer but also initiated new infection of resident host target cells [35] . Small numbers of CD4+ T cells that migrated into the epithelial layer through an active process were sufficient to transmit infection. In the same culture setting, similar results were obtained with human cells and HIV-1 [35] .
Several of the studies reported here indicate that repeated inoculations of SIV/HIV-infected cells may be required to efficiently transmit infection in animals. This raises the problem of allo-immunization of the receiver against the MHC of the different donors. Indeed, in humans, monogamous couples practicing unprotected sex develop reciprocal allo-immunization against the partner. The same phenomenon has been described in rhesus macaques inoculated repeatedly by the vaginal or rectal route with PBMCs from different donors [36] . As a consequence, the repeated inoculation of a very small number of infected cells may actually initiate an immune response in the receiver that may confer a protection against infection by the cell-associated virus. Such an impact on vaccine outcomes has been reported for free SIV viral particles. SIV and HIV are enveloped viruses, and the free particles carry MHC class I molecules at their surface. We and other have clearly shown that anti-MHC antibodies generated by vaccines based on chemically inactivated viral particles have significant impact on the outcome of SIV/HIV vaccine challenge in nonhuman primates [37] [38] [39] [40] . On the other hand, immune activation of recipient mucosal cells induced by exposure to allogeneic donor cells could enhance SIV/HIV transmission.
The dose required to achieve infection after mucosal exposure to cell-free virus in nonhuman primates could be easily estimated from the many vaccine, microbicide, and preexposure and postexposure prophylaxis challenge studies. Approximately 1000-5000 copies of viral RNA are required to transmit infection to 50% of animals after vaginal exposure of female macaques to SIVmac251 or SHIV culture supernatants. Conversely, there is very little information regarding the infectious dose required to infect nonhuman primates with cell-associated SIV. From our previous work we have estimated to approximately 10 5 viral DNA copies the dose to transmit infection to 50% of female macaques [33] . This finding in our nonhuman primate model is compatible to current knowledge on natural HIV infection in humans. By extrapolation, decreasing the dose we used in macaques by 100-1000 times should result in a transmission efficacy of 0.5%-0.05%, not so far different from that reported during male to female transmission in humans (0.3%-0.003%). Considering the volume of a single ejaculate (2-3 mL) in humans, we may therefore assume that an inoculum containing 10 000-80 000 copies of HIV DNA, corresponding to approximately to 1000-100 000 infected cells, may be sufficient to transmit the virus during sexual contacts.
EFFECTS OF SEMINAL PLASMA ON SEMINAL LEUKOCYTES IN MACAQUES
Seminal plasma and spermatozoa are not required to obtain infection in macaques after cervicovaginal exposure to cell-free or cell-associated SIV [33, 41] . However, seminal plasma is a very complex fluid, containing many factors that may either facilitate or limit HIV-1 mucosal transmission [42] . A tendency to favor transmission was reported when low concentrations of cell-free SIV inoculum were mixed with seminal plasma before mucosal inoculation of macaques [41, 43] . The influence of seminal plasma on cell-associated SIV has not yet been reported, although it could affect the viability and function of leukocytes present in semen. The pH of macaque semen is slightly basic, ranging from 7 to 9; this is similar to the pH of human semen (average, 7.7) and as such should not affect leukocyte survival [44] . However, other components of seminal plasma may be cytotoxic to leukocytes [42] , and seminal plasma has been shown to downregulate surface expression of CD4 on blood T cells ex vivo, due
to not yet clearly identified factors. Conversely, CCR5 is upregulated on seminal plasma-treated T cells, and this may promote the preferential transmission of R5-tropic strains [9] . Further work is needed to determine whether seminal plasma has any such activities on virus-infected cells in semen and on cell-associated SIV/HIV infectivity in vivo. Multiple cytokines that may impact virus transmission and increase the potential for independent viral replication within the seminal tract are found in semen of human [45] and macaques. As in humans, SIV-infected macaques with increased leukocyte numbers in semen have higher levels of inflammation markers that are correlated with blood and seminal plasma viral load during primary SIV infection [16] . The inflammatory status induced by SIV infection, especially during acute infection, may favor cell-associated virus transmission. Indeed, proinflammatory cytokines (eg, interleukin 1α, interleukin 6, or interleukin 15), may trigger activation of infected cells, thereby boosting viral replication. In addition, high levels of chemokines in semen (eg, CCL5, CCL3, and interleukin 8) may induce the migration of mucosal resident virus target cells toward the epithelial surface and into the epithelium along a chemokine gradient. On the other hand, the chemokines CCL3, CCL4, and CCL5 may have antiviral properties by inhibiting virus binding to the CCR5 coreceptor; however, this activity may not influence cell-to-cell transmission.
Semen clusterin is a DC-SIGN ligand and is able to interfere in the capture of HIV-1 by DC-SIGN. Semen clusterin seems to not be the only DC-SIGN ligand present in semen, but the identification and the contribution of other DC-SIGN ligands need further studies [46] . SIV-specific immunoglobulin G, frequently detected in semen of infected macaques, may also affect SIV transmission, although very few studies have addressed this question [5] . These antibodies titers are lower than those in blood and do not correlate with local viral shedding. Their capacity to impact viral transmission in macaques remains to be elucidated.
HOST MUCOSAL ENVIRONMENT
The normal rhesus macaque vaginal flora differs from the normal human flora and shows similarities to the human bacterial vaginosis, with a predominance of genera such as Streptococcus, Peptoniphilus, Gardnerella-like organisms, and other Corynebacterium organisms over Lactobacillus species [47] . In contrast, the vaginal flora of cynomolgus and pig-tailed macaques has been reported be closer to the normal human genital microbiota [48] . Recent, yet-to-be-published data, however, challenge these findings by indicating that cynomolgus macaques seem to present vaginal microbiota similar to that of the rhesus macaque. It is nevertheless unclear whether such differences may be associated with species, the breeding origin, or the evaluation by culture, on which lactobacilli do grow even if they are undetectable by a Nugent scoring system. Vaginal colonization of cynomolgus macaques with lactobacilli has proven difficult. How this may affect cell-associated SIV transmission has not been addressed.
The healthy vaginal environment in humans is acidic, with a pH ranging from 4 to 6, and cell-free HIV-1 can be inactivated by low pH [49] . For cell-free virus, the buffering capacity of semen, which is slightly alkaline, may play an important role for the infectivity, whereas cell-associated virus may be relatively protected and not impacted by pH decreases in the vaginal environment. In the rhesus, cynomolgus, or pig-tailed macaque model, the pH of the vaginal environment ranges from 6 to 8 [50, 51] .The infectivity of cell-free SIV/SHIV may then be increased in the macaque model.
In the female genital tract, seminal plasma induces the production of interleukin 6, interleukin 8, granulocyte macrophage colony-stimulating fact, and CCL2, inflammatory cytokines implicated in the recruitment and activation of leukocytes [52] . Moreover, high concentrations of TGF-β in semen, which has strong immunosuppressive activity and may modulate the immune response to pathogens following intercourse by inducing regulatory T-cell differentiation, may limit the host reaction to cell-associated SIV/HIV [53, 54] . Finally, coinfection with other sexually transmitted pathogens may also increase the production of infectious virus by infected leukocytes.
CONCLUSIONS
There are converging arguments from in vitro and ex vivo studies indicating that SIV/HIV-infected cells present in semen are able to transmit infection. Studies in nonhuman primates demonstrate that the male genital tract seeds the semen with cells, including CD4+ lymphocytes and macrophages, which are productively infected with SIV. It is technically difficult to collect leukocytes from semen of SIV-infected macaques in sufficient numbers to design studies for experimental transmission in animals. For these reasons, so far there is no direct proof that SIV-infected semen leukocytes obtained from infected macaques can transmit infection after mucosal inoculation. All reported studies used either in vitro-infected PBMCs or in vivo-infected splenocytes. This may not fully reflect the nature and biology of infected leukocytes present in semen. In addition, viruses seeding the seminal plasma, as both cellfree particles or harbored by semen leukocytes, may significantly differ from isolates obtained from blood or lymphoid tissues and amplified in in vitro cultures and commonly used in the vast majority of challenge studies. Finally, genital secretions are much more complex than culture supernatants, but most mucosal viral challenge studies in nonhuman primate models have failed to use semen as the delivery vehicle and therefore may not accurately represent human exposure to HIV-1 secreted in body fluids.
For all of these reasons, increased efforts are required to develop models that recapitulate the complexity of natural sexual transmission, including the mucosal microenvironment and body fluids and the diversity of viral components naturally found in mucosal secretions, with the aim to improve the relevance of animal models for HIV/AIDS pathogenesis studies and prevention. 
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